These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 650909)

  • 1. Prostaglandin E2 and epinephrine participate in cyclical reduction of coronary blood pressure and flow.
    Uchida Y; Yoshimoto N; Murao S
    Jpn Heart J; 1978 Mar; 19(2):281-96. PubMed ID: 650909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin I2 on cyclical reductions of coronary blood flow.
    Uchida Y; Murao S
    Jpn Circ J; 1979 Jul; 43(7):645-52. PubMed ID: 387990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
    Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
    Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thromboxane synthetase inhibitors on cyclical reduction of coronary blood flow in dogs.
    Uchida Y; Murao S
    Jpn Heart J; 1981 Nov; 22(6):971-5. PubMed ID: 7040725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
    Folts JD; Rowe GG
    Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical reduction in blood flow of partially constricted coronary artery in dogs. II. An arteriographic study.
    Uchida Y; Yoshimoto N; Murao S; Inoue K
    Jpn Circ J; 1977 Nov; 41(11):1221-30. PubMed ID: 592474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses.
    Ashton JH; Ogletree ML; Michel IM; Golino P; McNatt JM; Taylor AL; Raheja S; Schmitz J; Buja LM; Campbell WB
    Circulation; 1987 Oct; 76(4):952-9. PubMed ID: 3652429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostaglandins and thromboxane A2 on the coronary circulation of adult dogs and puppies.
    Wang HH; Kulkarni PS; Eakins KE
    Eur J Pharmacol; 1980 Aug; 66(1):31-41. PubMed ID: 7408964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro.
    Frank P; Novak RF
    Anticancer Res; 1986; 6(5):941-7. PubMed ID: 3467648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of prostacyclin and thromboxane A2 in the cardiovascular system].
    Ismailov ShI; Val'dman AV
    Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
    Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
    Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilatation in the dog.
    Capurro NL; Lipson LC; Bonow RO; Goldstein RE; Shulman NR; Epstein SE
    Circulation; 1980 Dec; 62(6):1221-7. PubMed ID: 7438358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
    Folts JD; Crowell EB; Rowe GG
    Circulation; 1976 Sep; 54(3):365-70. PubMed ID: 947567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandin I2 and thromboxane A2 in recurring reduction of carotid and cerebral blood flow in dogs.
    Uchida Y; Murao S
    Stroke; 1981; 12(6):786-92. PubMed ID: 7029792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
    Awara W; Hillier K; Jones D
    Immunology; 1986 Dec; 59(4):557-62. PubMed ID: 3468061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.